Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Early-Feasibility Study to Evaluate the Safety and Effectiveness of ETX-4143 2.0 Device in Subjects With Eye Pain

NCT06479382 is registered in ClinicalTrials.gov with EyeCool Therapeutics, Inc. as lead sponsor.

NCT NCT06479382
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06479382 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Early-Feasibility Study to Evaluate the Safety and Effectiveness of ETX-4143 2.0 Device in Subjects With Eye Pain
Lead sponsor
EyeCool Therapeutics, Inc.
Phase
Not applicable
Overall status
Completed
Start date
August 1, 2024
Completion date
November 29, 2024
Enrollment
31 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

eye pain